ACT Capital Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$241K Hold
16,500
0.33% 34
2022
Q2
$297K Hold
16,500
0.42% 35
2022
Q1
$492K Hold
16,500
0.52% 34
2021
Q4
$716K Hold
16,500
0.52% 37
2021
Q3
$1.18M Hold
16,500
0.61% 34
2021
Q2
$1.9M Buy
+16,500
New +$1.9M 0.97% 25